Accelerate access. Extend adherence. Deliver value.
Sciensus is a leading European hub of integrated services with 30 years’ experience in navigating the complex European healthcare ecosystem to maximise patient access to medicines, product launches and full commercialisation.
Our key services
Leading our partners to connect patients to life-changing therapies faster – with integrated solutions that drive access, efficiency and better outcomes across Europe.
End-to-end dispense and delivery
Safe, compliant, pan-European logistics – from import and title to last-mile delivery and order-to-cash.
- Supply chain management
- Pharmaceutical storage and distribution
- Dispense and delivery
- Purchasing and cash collection
- Packaging and labelling
Treatment delivery and ongoing engagement
Specialist nurses and digital tools supporting patients at home – improving adherence, persistence and outcomes.
Market access support
Navigate Europe’s complex regulatory, pricing and reimbursement systems to bring therapies to patients faster.
Clinical study support and real-world evidence
Extend study reach, capture real-world insights and generate the evidence needed for strategic decision-making.
Cancer services
We provide at-home cancer care for 4,000 patients each year, delivering over 400 SACT regimens through our specialist nurses and dedicated compounding unit.
Health system efficiencies
Relieving NHS and health system capacity pressures through homecare services, digital tools and innovative ways to support clinical teams.
Global expertise, local execution
Sciensus offers a single partner to manage the complexity of commercialising a drug across Europe – with a faster route to reaching and supporting patients and gathering insights to maximise your European launch.
Expertise across therapeutic areas
With a deep understanding of chronic conditions, rare and speciality diseases and cancer, we combine breadth of expertise with bespoke solutions to handle even the most complex therapeutic needs.
Cancer
We provide at-home cancer care for 4,000 patients each year, delivering over 400 SACT regimens through our specialist nurses and dedicated compounding unit.
Chronic conditions
We support 300,000 patients each year with digitally-enabled, clinician-led care for complex and chronic conditions, improving adherence by over 10% and generating real-world insights across 70 therapy areas.
Rare and speciality diseases
We provide access to rare and speciality medicines across Europe, supplying 300,000 units annually to over 4,000 hospitals and pharmacies, with $400m of orphan drugs traded each year.
Our impact
With 30+ years of in-market expertise, Sciensus has superior access to patients – our distribution and clinical care infrastructure enables us to help you get the right drug to the right patients faster and then we can provide the personalised support to drive adherence, reduce drop-off and collect real world data.
0
patient interactions
0
patients treated annually
0 +
regimens supported across 125 different medicines
0
relationships with hospitals, clinics and pharmacies in Europe
Scalability
Expertise
Bespoke solutions
As a strategic partner, they have exceeded our expectations by finding global patients, who need our drugs, and enabling them to receive their life-extending medications.
Chief Commercial Officer at leading US Biotech company
Get in touch
Thank you for your interest in Sciensus. Whether you’re seeking information, partnership opportunities, or want to refer a patient, our dedicated team is here to assist you. Please fill out the form on the right, and one of our multi-lingual representatives will get in touch with you promptly.
